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A multicomponent ultraviolet (UV) spectrophotometric method was developed and validated for simultaneous 
determination of delapril (DEL) and indapamide (IND) in tablets employing the partial least squares regression (PLSR) 
approach. The PLSR method was developed by a multilevel factorial design using 25 synthetic mixtures of drugs and a 
significant predict model (p < 0.05) were obtained at 225 nm for DEL (R
2
 = 0.9992) and 243 nm for IND (R
2
 = 0.9997). 
Validation parameters such as the specificity, linearity, precision, accuracy and robustness were evaluated in accordance 
with the ICH requirements, giving satisfactory results within the acceptable range. The proposed PLSR method was 
successfully applied for simultaneous determination of DEL and IND in fixed dose combinations and can be used as 
simple alternative to separation techniques. 
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Introduction 
 
Hypertension is one of the most important risk 
factors of cardiovascular diseases and thus to achieve 
blood pressure targets as soon as possible is imperative. 
Combination therapy for antihypertensive treatment is 
being increasingly recommended once monotherapy is 
not the adequate control of blood pressure in most 
patients (1,2). 
A well-established antihypertensive combination 
can be observed for delapril (DEL) and indapamide 
(IND), an angiotensin-converting enzyme inhibitor and 
a thiazide diuretic, respectively. Due to the additive and 
synergistic mechanisms of actions of agents from these 
two drug classes, a low dose was required for effective 
antihypertensive effect. DEL 30 mg and IND 2.5 mg 
have been combined in a fixed tablet, offering the 
convenience and good tolerability for most patients 
(3,4). The chemical structures of drugs are shown in 
Figure 1. 
 
 
 
Figure 1 Chemical structures of DEL (a) and IND (b). 
 
The tablet pharmaceutical dosage form is 
commercially available, but at the moment, there are no 
published methods for simultaneous analysis of DEL 
and IND as raw material or finished product. However, 
the current literature reveals a few number of 
publications related of drugs in single dosage form or in 
association with others drugs. For DEL determination, 
these studies were performed by liquid chromatography 
(5), liquid chromatography-tandem mass spectrometry 
(6), capillary electrophoresis (7), and derivative 
spectrophotometry (8). On the other hand, British 
Pharmacopoeia, European Pharmacopoeia and United 
States Pharmacopoeia present official methods by liquid 
chromatography and spectrophotometry for IND assay 
in tablets and raw materials. Many of these methods use 
expensive and hazardous chemicals, require expertise, 
making the process a challenge for the environment, 
time consuming and complex. 
The use of spectrophotometric methods provides 
practical and economic advantages over other 
instrumental techniques and could be a useful 
alternative for quality control routine. The development 
of a more convenient, simple, less time-consuming and 
environmentally friendly spectrophotometric method is 
desirable. However, the simultaneous determination of 
two or more active components in different 
pharmaceutical preparations without previous chemical 
separation is a common analytical problem (9,10). 
The application of multivariate calibration 
approaches in spectrophotometry offers advantage in 
complex systems resolution and mixtures analysis. 
Among the chemometric techniques applied to 
multicomponent analysis, the partial least squares 
regression (PLSR) has been successfully used in 
different quantitative assays of pharmaceutical 
formulations (11-14). 
Considering the absence of analytical methods for 
the simultaneous determination of DEL and IND in 
tablets, we decided to develop and validate a simple, 
fast and cost-effective multicomponent UV 
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spectrophotometric method employing the PLSR 
approach, contributing to research of green and 
practical alternatives methods for quality control and 
assuring the therapeutic efficacy of products. 
 
 
Experimental 
 
Chemicals 
 
DEL and IND reference substances were kindly 
donated by Chiesi Farmaceutici (Parma, Italy) and Prati 
Donaduzzi (Toledo, Brazil), with a purity of 99.6% and 
99.4%, respectively. Delapride® tablets (containing 30 
mg and 2.5 mg of DEL of IND) were obtained from 
commercial source and used within the expiration date. 
The dosage form excipients (lactose monohydrate, 
magnesium stearate, hydroxypropyl cellulose and low 
substituted hydroxypropyl cellulose) were all 
pharmaceutical grades and acquired from different 
suppliers. Analytical grade ethanol was obtained from 
Vetec Química Fina Ltda (Rio de Janeiro, RJ, Brazil) 
and Êxodo Científica (Hortolândia, SP, Brazil). For all 
the analyses, ultrapure water (Milli-Q® Direct Water 
Purification System, Merck Millipore Corporation, 
Darmstadt, Germany) was used. 
 
Analytical Solutions 
 
The reference solutions were prepared by weighing 
the equivalent of 30 mg of DEL and 2.5 mg of IND 
chemical standards and diluted to volume with ethanol, 
obtaining the concentration of 300 µg mL
-1
 and 25 µg 
mL
-1
 for DEL and IND, respectively. To prepare the 
sample solutions, tablets containing 30 mg of DEL and 
2.5 mg of IND were accurately weighed and crushed to 
fine powder. An appropriate amount was transferred 
into an individual 100 mL volumetric flask, diluted to 
volume with ethanol, kept in vortex for 5 min, sonicated 
for 15 min and filtered through a 0.45 µm membrane 
filter (Millipore), obtaining theoretical concentrations of 
300 µg mL
-1
 and 25 µg mL
-1
 for DEL and IND, 
respectively. The reference solutions were stored at 2-8 
°C, protected from light and daily diluted to an 
appropriate concentration in ethanol daily. 
 
UV Apparatus 
 
A double beam UV‐Visible spectrophotometer 
(PerkinElmer, Singapore), model Lambda 35, was used 
in this study. The instrument was equipped with 1 cm 
quartz cells, with PerkinElmer UV WinLab software 
(version v5) for instrument control, data acquisition and 
analysis. All spectra were recorded in the range 200–
300 nm with 0.1 nm intervals, at scanning speed of 960 
nm min
-1
, with a fixed slit to lead to a spectral 
resolution of 1 nm. 
 
 
UV Procedure 
 
The multivariate method was performed by the 
partial least squares regression (PLSR) mode. The 
PLSR experiment, using 5 concentrations of the isolated 
and combined drugs, was performed using a multilevel 
factorial design with 2 factors and 5 combinations, as 
shown in Table 1. The resulted spectral data matrix 
consisted of 25 rows representing different samples at 
the concentration range of 0-108 µg mL
-1
 for DEL and 
0-9.0 µg mL
-1
 for IND. The PLSR analyses were 
performed using the software Minitab 17 (Minitab Inc, 
State College, PA, USA). All UV measurements were 
recorded using ethanol as blank solution. 
 
 
Table 1 Selected multilevel factorial design of the calibration 
set mixtures for PLSR method. 
 
Run 
order 
Standard 
order 
DEL 
(μg mL-
1) 
IND 
(μg mL-
1)
 
Absor
bance 
225 
(nm) 
Absor
bance 
243 
(nm) 
1 8 36 5 0.411 0.289 
2 20 84 9 0.832 0.528 
3 7 36 3 0.339 0.186 
4 14 60 7 0.626 0.407 
5 11 60 0 0.378 0.045 
6 3 0 5 0.192 0.260 
7 12 60 3 0.475 0.198 
8 5 0 9 0.330 0.465 
9 23 108 5 0.827 0.332 
10 16 84 0 0.504 0.055 
11 18 84 5 0.689 0.318 
12 6 36 0 0.220 0.026 
13 13 60 5 0.547 0.298 
14 15 60 9 0.694 0.507 
15 22 108 3 0.747 0.225 
16 1 0 0 0.007 0.001 
17 24 108 7 0.912 0.434 
18 17 84 3 0.622 0.213 
19 21 108 0 0.654 0.070 
20 10 36 9 0.547 0.494 
21 2 0 3 0.119 0.157 
22 4 0 7 0.284 0.365 
23 9 36 7 0.481 0.387 
24 25 108 9 1.303 0.548 
25 19 84 7 0.766 0.416 
 
 
Validation Procedure 
 
The method was validated in accordance with the 
International Conference on Harmonisation (ICH) 
requirements, involving the specificity, linearity, 
precision, accuracy, robustness and limits of detection 
(LD) and quantitation (LQ) parameters (15,16). 
 
Results and Discussion 
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Method Development 
 
In order to establish the assay parameters, different 
solvents (water, ethanol and hidroethanolic mixture) 
were investigated to develop a suitable 
spectrophotometric method for the simultaneous routine 
analysis of DEL and IND in tablets. Due to capability to 
dissolve both drugs, low toxicity and absorbance 
response, ethanol was selected for the sample 
preparation and used as final diluent. 
The UV spectra of DEL (60 µg mL
-1
) and IND 
(5 µg mL
-1
) reference solutions are shown in Figure 2. 
DEL spectrum has a high absorption band in the region 
from 200 to 230 nm. On the other hand, the IND 
spectrum has shown two broad bands from 200 to 220 
nm and 230 to 260 nm. The wavelengths regions can be 
suitable for a quantitative determination of the single 
drugs. However, the spectral overlapping of drugs 
precludes the use of direct UV spectrophotometry or 
univariate calibration for their simultaneous 
determination, being required another approach or 
analytical instrument. 
 
 
 
 
Figure 2 Overlay UV spectra of DEL reference standard (60 
μg mL-1), IND reference standard (5 μg mL-1) and placebo. 
 
 
The method development turned to the application 
of a multicomponent chemometric mode by PLSR. 
During the optimization, the compositions of binary 
mixtures of reference solutions were chosen randomly 
to avoid correlation between the concentrations of two 
substances. Twenty-five solutions of drugs were 
randomly selected and used for calibration model. The 
concentration ranges from 0.0-108 µg mL
-1
 (DEL) and 
0.0-9.0 µg mL
-1
 (IND) were analized at wavelengths of 
222, 225, 228, 240, 243 and 246 nm (the wavelengths 
contemplate the regions of best spectral intensity for 
both drugs). The data obtained were plotted in Minitab 
giving statistical graphs (Figure 3). 
The multicomponent mode was adequate for all 
verified wavelengths, showing the best determination 
coefficient value in 225 nm (R
2
 = 0.9992) and 243 nm 
(R
2
 = 0.9997) for the determination of DEL and IND, 
respectively. Moreover, the significance of the predict 
model (p < 0.05) were observed by one-way variance 
analysis (ANOVA) and the standardized residuals 
graphs show homoscedastic behavior, confirming the 
applicability of the multicomponent analysis method for 
the mixing drugs concentrations. 
 
 
 
Figure 3 Results obtained from the PLSR analysis of the 
mixture of different concentrations of DEL and IND at 
wavelengths of 225 nm (a) and 243 nm (b). 
 
 
Method Validation 
 
Specificity 
 
As previously mentioned, an overlap between UV 
spectra of DEL and IND was observed. Thus, the UV 
specificity was accessed using the PLSR approach by 
comparing the obtained spectra from the synthetic 
mixture of standard drugs and placebo solutions 
containing the same excipients of the commercial 
products. 
All the solutions were scanned in the selected 
wavelength (225 nm for DEL and 243 nm for IND). No 
spectral interference was observed at specificity tests, 
demonstrating the ability of the method to quantify the 
analytes even in the coexistence of both in the 
pharmaceutical formulation. 
 
Linearity 
 
The analytical curves were obtained with seven 
concentrations of reference solution in the concentration 
range of 42-78 μg mL-1 (42, 48, 54, 60, 66, 72 and 78 
μg mL-1) for DEL and 3.5-6.5 µg mL-1 (3.5, 4.0, 4.5, 
5.0, 5.5, 6.0 and 6.5 μg mL-1) for IND. Each solution 
was prepared in triplicate and analyzed by the 
developed UV method. The results were evaluated by 
the least square regression and by ANOVA. 
The linearity was proved by the representative linear 
equations for DEL (y = 0.0097x + 0.0345; R
2
 = 0.9965) 
and IND (y = 0.0709x + 0.0095; R
2
 = 0.9990). 
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Moreover, the ANOVA was performed to verify the 
good fitting of the linear method and the results showed 
significant linear regression (p < 0.05) and no deviation 
from linearity for drugs (p > 0.05). 
 
LD/LQ 
 
The LD/LQ parameters are not a requirement for 
drug assay, however, it is important to demonstrate the 
method sensitivity. The limits were calculated based on 
the standard deviation of the response (y-intercepts of 
regression lines) and the slope using three independent 
analytical curves, as defined by ICH (15). The LQ/LD 
were 1.61/5.35 μg mL-1 for DEL and 0.32/1.07 μg mL-1 
for IND. 
 
Precision 
 
The UV method precision was determined by 
studying the intra-day (repeatability) and inter-day 
precision (intermediate precision). Repeatability was 
evaluated assaying six determinations at the same 
concentration (60 μg mL-1 and 5 μg mL-1 for DEL and 
IND, respectively), during the same day, under the same 
experimental conditions. The intermediate precision 
was analyzed by comparing the results obtained on 
three different days. 
The experimental results were expressed as relative 
standard deviation (RSD) and are presents in Table 2. 
The method variability were within the acceptable range 
with RSD values of less than 2.0% for DEL and IND 
determinations, and thus, indicating that the analytical 
method has excellent precision. 
 
 
Table 2 Intra-day and inter-day precision data of UV method 
for DEL and IND in tablets. 
 
  DEL IND 
Day  
 
Assay1 
(%) 
RSD2 
(%) 
Assay1 
(%) 
RSD2 
(%) 
1  99.56 1.39 99.18 0.95 
2  98.77 1.96 100.18 2.12 
3  101.16 1.86 99.04 1.83 
Mean3  99.83 1.94 99.47 1.69 
1Mean of six replicates, 2RSD (Relative standard deviation), 
3Mean of eighteen replicates. 
 
 
Accuracy 
 
This parameter was determined by the recovery test 
that consisted on adding known amounts of reference 
solution to the placebo solution (prepared according to 
the specificity test). Aliquots of the initial reference 
solutions (300 µg mL
-1
 of DEL and 25 µg mL
-1
 of IND) 
were accordingly transferred to the placebo solutions 
obtaining the theoretical concentrations of 48, 60 and 72 
µg mL
-1
 of DEL and 4, 5 and 6 µg mL
-1
 of IND. The 
samples corresponding to 80%, 100% and 120% of 
work solutions. 
The analysis was performed on three subsequent 
days and the results were expressed as the recoveries 
percentage of DEL and IND from the comparison 
between theoretical and experimental concentrations 
(Table 3). A satisfactory mean percentage data of DEL 
(100.68%) and IND (101.60%) were obtained, 
evidencing the accuracy of the method. 
 
 
Table 3 Recovery test for DEL and IND by UV method. 
Drug 
Theoretical 
(μg mL-1) 
Experimental1 
(μg mL-1) 
Accuracy2 
(%) 
RSD3 
(%) 
 48 49.42 102.95 
1.21 DEL 60 60.29 100.49 
 72 73.15 101.60 
 4 4.11 102.78 
1.10 IND 5 5.03 100.56 
 6 6.09 101.47 
1Mean of three replicates, 2Percentage data recoveries, 3RSD 
(Relative standard deviation). 
 
 
Robustness 
 
The robustness was performed by analyzing the 
samples under different modifications in the methods 
settings, including the wavelength (nm) ethanol 
supplier and the sample preparation. Only the stirring 
time was evaluated, maintaining the same sonication 
period. The results (percentages of DEL and IND in the 
commercial tablets) and the experimental range of the 
selected variables evaluated are shown in Table 4. No 
significant changes (RSD) in simultaneous drugs 
determination were observed under the variations in the 
wavelength (0.48% for DEL and 0.91% for IND), 
ethanol supplier (0.78% for DEL and 1.48% for IND) 
and stirring time (0.93% for DEL and 1.16% for IND), 
thus showing the robustness of methods. 
Additionally, the stability of both reference and 
sample solution used during analysis were evaluated. 
They were placed at 2-8 ºC and also maintained at room 
temperature for 48 h and the assay results remained 
almost unchanged and no significant alteration relative 
to freshly prepared samples was observed (data not 
shown), showing the stability of the solutions within the 
indicated period, which was sufficient for the whole 
analytical process. 
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Table 4 Robustness testing of UV mehod for DEL and IND 
assay. 
 Assay1 (%) 
Factor Levels DEL  Levels IND 
Wavelength 
(nm) 
223 99.88  241 100.84 
225 100.84  243 101.13 
227 100.41  242 99.43 
 RSD2 0.48  RSD2 0.91 
Stirring time 
(min) 
4 101.00  4 100.75 
5 99.56  5 99.18 
6 99.88  6 101.40 
 RSD2 0.76  RSD2 1.14 
Ethanol 
supplier 
Ethanol 1 101.84  Ethanol 1 101.00 
Ethanol 2 100.52  Ethanol 2 100.77 
 RSD2 0.93  RSD2 0.16 
1Mean of three replicates, 2RSD (Relative standard deviation). 
 
 
Conclusions 
 
This study presents a multicomponent 
spectrophotometric method for the determination of 
DEL and IND in commercial formulations. The PLSR 
mode was successfully developed and proved to be able 
to resolving binary mixtures, presenting as is a safe 
alternative for the simultaneous analysis of drugs in 
their combination formulation. The method was 
validated according to ICH guideline, with adequate 
results of specificity, linearity, precision, accuracy, and 
robustness, showing over chromatographic methods due 
to its simplicity, rapidity, lower cost and dangerous 
residues. Moreover, the method can be used without 
any prior separation of drugs and tablet excipients, and 
can be conveniently used for the routine quality control. 
Thus, this work contributes to technical and scientific 
development of pharmaceutical sciences, providing an 
innovative analytical methodology for DEL and IND 
analysis. 
 
Acknowledgements 
 
The authors wish to thank CNPq (Conselho 
Nacional de Desenvolvimento Científico e 
Tecnológico) and FAPERJ (Fundação de Amparo à 
Pesquisa do Estado do Rio de Janeiro) for the financial 
support. 
 
References 
 
1. Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, 
D.T., Murray, C.J.L. Global burden of disease and 
risk factors. Lancet. 2006; 367: 1747-1757. 
2. Gradman, A.H., Basile, J.N., Carter, B.L., Bakris, 
G.L. Combination therapy in hypertension. J Am 
Soc Hypertens. 2010; 4(1): 42-50. 
3. Cavalieri, L., Cremonesi, G. Delapril plus 
indapamide: a review of the combination in the 
treatment of hypertension. Clin Drug Invest. 2007; 
27: 367-380. 
4. Circelli, M. Efficacy and safety of 
delapril/indapamide compared to different ACE-
inhibitor/hydrochlorothiazide combinations: a meta-
analysis. Int J Gen Med. 2012; 5: 725-734. 
5. Todeschini, V., Meira, A.S., Sangoi, M.S., Barth, 
A.B, Paim, C.S., Volpato, N.M. Simultaneous 
determination of delapril and manidipine in a 
pharmaceutical formulation by a stability-indicating 
RP-LC method. J Liq Chromatogr Rel Technol. 
2012; 35: 603-620. 
6. Todeschini, V., Sangoi, M.S., Volpato, N.M. 
Delapril and manidipine measurements by liquid 
chromatography-tandem mass spectrometry in 
pharmaceutical formulation. Eur J Mass Spectrom. 
2011; 17: 287-296. 
7. Todeschini, V., Meira, A.S., Sangoi, M.S., Miron, 
D., Lange, A.D., Volpato, N.M. Stability-indicating 
micellar electrokinetic chromatography technique 
for simultaneous measurement of delapril and 
manidipine from their combination drug 
formulation. J AOAC Int. 2014; 97: 114-120. 
8. Todeschini, V., Barden, A.T., Sfair, L.L., Sangoi, 
M.S., Volpato, N.M. First-order derivative UV 
spectrophotometric method for simultaneous 
measurement of delapril and manidipine in tablets. 
Acta Chim Slov. 2013; 60(2): 335-342. 
9. Rojas, F., Ojeda, C. Recent development in 
derivative ultraviolet/visible absorption 
spectrophotometry: 2004-2008: A review. Anal. 
Chim. Acta. 2009; 635: 22-44. 
10. Ayoub, B.M. Development and validation of simple 
spectrophotometric and chemometric methods for 
simultaneous determination of empagliflozin and 
metformin: Applied to recently aproved 
pharmaceutical formulation. Spectrochim. Acta A: 
Mol Biomol Spectrosc. 2016; 168: 118-122. 
11. Darwish, H.W., Bakheit, A.H., Abdelhameed, A.S. 
Simultaneous quantitative analysis of olmesartan, 
amlodipine and hydrochlorothiazide in their 
combined dosage form utilizing classical and 
alternating least squares based chemometric 
methods. Acta Pharm. 2016; 66: 83-95. 
12. Glavanović, S., Glavanović, M., Tomišić, V. 
Simultaneous quantitative determination of 
paracetamol and tramadol in tablet formulation 
using UV spectrophotometry and chemometric 
methods. Spectrochim Acta A: Mol Biomol 
Spectrosc. 2016; 157: 258-264. 
13. Abdel-Halim, L.M., Abd-El Rahman, M.K., 
Ramadan, N.K., El Sanabary, H.F., Salem, M.Y. 
Comparative study between recent methods 
Drug Anal Res, 2017; 01, 50-55 
 
55 
manipulating ratio spectra and classical methods 
based on two-wavelength selection for the 
determination of binary mixture of antazoline 
hydrochloride and tetryzoline hydrochloride. 
Spectrochim Acta A: Mol Biomol Spectrosc. 2016; 
159: 98-105. 
14. Palabiyik, I.M., Onur, F., Yardimci, C., Özaltin, N. 
Simultaneous spectrophotometric determination of 
ezetimibe and simvastatin in pharmaceutical 
preparations using chemometric techniques. Quim 
Nova. 2008; 31(5): 1121-1124. 
15. International Conference on Harmonization (ICH) 
of Technical Requirements for the Registration of 
Pharmaceutical for Human Use. Validation of 
Analytical Procedures: Text and Methodology 
Q2(R1). Geneva, Switzerland, 2005. 17p. 
16. Food and Drug Administration (FDA), Center for 
Drug Evaluation and Research. Guidance for 
Industry: Analytical Procedures and Methods 
Validation for Drugs and Biologics. Silver Spring, 
USA, 2015. 18p. 
 
 
 
